214 related articles for article (PubMed ID: 2286420)
1. Effects of morphine, buprenorphine, pentazocine and nalorphine on acquisition and extinction of active avoidance responses in rats.
Saha N; Datta H; Sharma PL
Indian J Physiol Pharmacol; 1990 Jul; 34(3):179-82. PubMed ID: 2286420
[TBL] [Abstract][Full Text] [Related]
2. Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion.
Leander JD; McMillan DE; Harris LS
J Pharmacol Exp Ther; 1975 Nov; 195(2):271-8. PubMed ID: 1237618
[TBL] [Abstract][Full Text] [Related]
3. [Secondary-reinforcing effects of opiate agonists in the mouse].
Zvartau EE; Kovalenko VS
Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(6):1069-76. PubMed ID: 3031897
[TBL] [Abstract][Full Text] [Related]
4. Effects of narcotics and narcotic antagonists on operant behavior.
McMillan DE
Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
[No Abstract] [Full Text] [Related]
5. [Morphine antagonists (pentazocine, nalorphine, naloxone and buprenophine)].
Fournier T; Besserve P; Lefèvre P; Lephay A; Ossart M
Cah Anesthesiol; 1988 May; 36(3):223-34. PubMed ID: 2840178
[No Abstract] [Full Text] [Related]
6. Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties.
Tang AH; Franklin SR
Pharmacol Biochem Behav; 1983 Jun; 18(6):873-7. PubMed ID: 6889416
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of analgesic effects of morphine, buprenorphine and pentazocine in rats receiving somatic and visceral stimulation].
Iwasaki H; Ohmori H; Kobayashi I; Omote K; Kawamata M; Namiki A
Masui; 1994 Nov; 43(11):1648-52. PubMed ID: 7861593
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice.
Aguilar MA; Miñarro J; Simón VM
Neurobiol Learn Mem; 1998 Mar; 69(2):92-105. PubMed ID: 9619990
[TBL] [Abstract][Full Text] [Related]
9. High doses of vasopressin delay the onset of extinction and strengthen acquisition of LiCl-induced conditioned taste avoidance.
Hayes UL; Chambers KC
Physiol Behav; 2005 Mar; 84(4):625-33. PubMed ID: 15811398
[TBL] [Abstract][Full Text] [Related]
10. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
Hoffmeister F; Wuttke W
Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
[No Abstract] [Full Text] [Related]
11. Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area.
Darbandi N; Rezayof A; Zarrindast MR
Physiol Behav; 2008 Jul; 94(4):604-10. PubMed ID: 18479719
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
[TBL] [Abstract][Full Text] [Related]
13. N-Methyl-D-aspartate receptors in the ventral tegmental area are involved in retrieval of inhibitory avoidance memory by nicotine.
Ahmadi S; Zarrindast MR; Nouri M; Haeri-Rohani A; Rezayof A
Neurobiol Learn Mem; 2007 Oct; 88(3):352-8. PubMed ID: 17707662
[TBL] [Abstract][Full Text] [Related]
14. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
Hiyama T; Shintani S; Tsutsui M; Yasuda Y
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
[TBL] [Abstract][Full Text] [Related]
16. Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
Lukas SE; Brady JV; Griffiths RR
J Pharmacol Exp Ther; 1986 Sep; 238(3):924-31. PubMed ID: 3746670
[TBL] [Abstract][Full Text] [Related]
17. Agmatine inhibits morphine-induced drug discrimination in rats.
Su RB; Ren YH; Liu Y; Ding T; Lu XQ; Wu N; Liu ZM; Li J
Eur J Pharmacol; 2008 Sep; 593(1-3):62-7. PubMed ID: 18657533
[TBL] [Abstract][Full Text] [Related]
18. Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse.
Lelong-Boulouard V; Quentin T; Moreaux F; Debruyne D; Boulouard M; Coquerel A
Drug Alcohol Depend; 2006 Nov; 85(2):103-13. PubMed ID: 16720083
[TBL] [Abstract][Full Text] [Related]
19. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
20. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
